Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 1 (3 methoxyphenyl) ethylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116334022B reveals high-efficiency transaminase mutant for Rivastigmine intermediate. Offers superior yield and purity for scalable pharmaceutical manufacturing.